Human PSMA/FOLH1/NAALADase I Antibody
R&D Systems, part of Bio-Techne | Catalog # MAB42342
![Detection of PSMA/FOLH1 in LNCaP Human Cell Line by Flow Cytometry.](https://resources.bio-techne.com/images/products/antibody/mab42342_human-psma-folh1-mab-clone-460407-flow-cytometry-1692021161248.jpg)
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Lys44-Ala750
Accession # Q04609
Specificity
Clonality
Host
Isotype
Scientific Data Images for Human PSMA/FOLH1/NAALADase I Antibody
Detection of PSMA/FOLH1 in LNCaP Human Cell Line by Flow Cytometry.
LNCaP human prostate cancer cell line was stained with Mouse Anti-Human PSMA/FOLH1 Monoclonal Antibody (Catalog # MAB42342, filled histogram) or Mouse IgG2A isotype control antibody (MAB003, open histogram), followed by Phycoerythrin-conjugated Anti-Mouse IgG Secondary Antibody (F0102B). Staining was performed using our Staining Membrane-associated Proteins protocol.Applications for Human PSMA/FOLH1/NAALADase I Antibody
Flow Cytometry
Sample: LNCaP human prostate cancer cell line
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: PSMA/FOLH1/NAALADase I
Human prostate-specific membrane antigen (PSMA), a tumor marker in prostate cancer encoded by the FOLH1 gene, is a type II transmembrane zinc metallopeptidase that is most highly expressed in the nervous system, prostate, kidney, and small intestine (1, 2). The enzyme is also known as glutamate carboxypeptidase II (GCPII), folate hydrolase 1, folypoly-gamma-glutamate carboxypeptidase (FGCP), and N-acetylated-alpha-linked acidic dipeptidase I (NAALADase I). In the brain, PSMA hydrolyzes the neurotransmitter N-acetyl-Asp-Glu to produce glutamate, another neurotransmitter. Inhibition of brain PSMA activity is considered to be a promising approach for the treatment of neurological disorders associated with glutamate excitotoxicity, such as stroke, chronic pain, and amyotrophic lateral sclerosis (3). Intestinal PSMA hydrolyzes folylpoly-gamma -glutamates, facilitating the uptake of folate (4).
References
- Silver, D.A. et al. (1997) Clin. Cancer Res. 3:81.
- Carter, R.E. et al. (1996) Pro. Natl. Acad. Sci. USA. 93:749.
- Jackson, P.F. and Slusher, B.S. (2001) Curr. Med. Chem. 8:949.
- Heston, W.D. (1997) Urology 49:104.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional PSMA/FOLH1/NAALADase I Products
Product Documents for Human PSMA/FOLH1/NAALADase I Antibody
Product Specific Notices for Human PSMA/FOLH1/NAALADase I Antibody
For research use only